Wednesday, December 7, 2011

North American first at the Montreal Heart Institute: a patient treated with a disappearing heart device (Canada)

North American first at the Montreal Heart Institute: a patient treated with a disappearing heart device (Canada)The interventional cardiology team at the Montreal Heart Institute used the world's first drug eluting bioresorbable vascular scaffold to successfully treat a woman suffering from coronary artery disease. This landmark procedure was performed by Dr. Jean-Fran├žois Tanguay, interventional cardiologist and coordinator of the Coronary Unit, as part of the ABSORB EXTEND clinical trial. This successful intervention was a first in North America. The device is made of polylactide, a proven biocompatible material that is commonly used in medical implants such as dissolvable sutures. ABSORB has CE Mark and is authorized for sale in Europe. It is under clinical investigation around the world with more than 500 patients treated with the device

No comments: